Advertisement

Topics

Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update

08:34 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Immune Pharmaceuticals Inc. (NASDAQ:IMNP) (“Immune”) a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced financial results for the quart...

Other Sources for this Article

Immune Pharmaceuticals Inc.
Elliot Maza
investors@immunepharma.com

NEXT ARTICLE

More From BioPortfolio on "Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...